Metabolic Signature of Healthy Lifestyle and HCC
NCT03356535 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 294
Last updated 2017-11-29
Summary
Hepatocellular carcinoma (HCC) is the most common form of liver cancer and its incidence is increasing including in regions where hepatitis infection rates are low. This trend may be the result of increases in 'unhealthy lifestyle' factors. The main aim of this study is to identify metabolic signatures associated with healthy lifestyle behaviours and to relate these signatures to risk of developing HCC to investigate whether the metabolites were of predictive utility for HCC beyond data procured from questionnaires. To address this question, we exploited data from a large European cohort (EPIC) which includes detailed questionnaire-based data as well as metabolomic data.
Conditions
Sponsors & Collaborators
-
Imperial College London
collaborator OTHER -
Danish Cancer Society
collaborator OTHER -
University of Aarhus
collaborator OTHER -
Centre for Research in Epidemiology and Population Health (CESP)
collaborator OTHER -
Gustave Roussy, Cancer Campus, Grand Paris
collaborator OTHER -
German Cancer Research Center
collaborator OTHER -
German Institute of Human Nutrition
collaborator OTHER -
Hellenic Health Foundation
collaborator OTHER -
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
collaborator OTHER -
ISPO Cancer Prevention and Research Institute
collaborator UNKNOWN -
Federico II University
collaborator OTHER -
HuGeF Foundation
collaborator UNKNOWN -
Azienda Sanitaria Provinciale Ragusa
collaborator OTHER -
University of Tromso
collaborator OTHER -
Institut Català d'Oncologia
collaborator OTHER -
Ministry of Health - Government of the Principality of Asturias
collaborator OTHER_GOV -
Andalusian School of Public Health
collaborator OTHER_GOV -
Universidad de Murcia
collaborator OTHER -
Instituto de Salud Pública Gobierno de Navarra
collaborator UNKNOWN -
Subdirección de Salud Pública de Gipuzkoa
collaborator UNKNOWN -
Skane University Hospital
collaborator OTHER -
Umeå University
collaborator OTHER -
MORGEN-EPIC, Bilthoven
collaborator UNKNOWN -
Prospect-EPIC, Utrecht
collaborator UNKNOWN -
University of Oxford
collaborator OTHER - collaborator OTHER
-
International Agency for Research on Cancer
lead OTHER
Eligibility
- Min Age
- 30 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-08-01
- Primary Completion
- 2017-09-15
- Completion
- 2017-09-15
More Related Trials
-
Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients
NCT01798173 ·Status: COMPLETED ·Phase: NA
-
HCC Innervation Assessment
NCT06886763 ·Status: ACTIVE_NOT_RECRUITING
-
A Worldwide Score for Hepatocellular Cancer and Liver Transplantation
NCT03595345 ·Status: COMPLETED
-
Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies
NCT05613621 ·Status: ACTIVE_NOT_RECRUITING
-
ProspEXPO : Study of the Associations Between Hepatocellular Carcinoma and Chemical and Psychosocial Environmental EXPOsome
NCT07119957 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis
NCT03083002 ·Status: UNKNOWN
-
Influence of Social Determinants of Health on the Management of HCC in the French National Cohort Study CHIEF
NCT05128123 ·Status: ACTIVE_NOT_RECRUITING
-
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
NCT01034865 ·Status: COMPLETED
-
Head-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan City
NCT07010198 ·Status: RECRUITING
-
The Surveillance of Hepatocellular Carcinoma
NCT05286099 ·Status: UNKNOWN
-
Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients
NCT06550739 ·Status: COMPLETED
-
Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and Recommendations
NCT04189809 ·Status: UNKNOWN
-
Development of a Neuronal Microscope
NCT06311396 ·Status: COMPLETED ·Phase: NA
-
Hepatocellular Cancer (HCC) Screening in Zhongshan City
NCT02501980 ·Status: UNKNOWN
-
Circulating Tumor Cell Detection in Hepatocellular Carcinoma
NCT05297955 ·Status: COMPLETED
-
Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC
NCT04221347 ·Status: UNKNOWN
-
Liver Cancer Prevention Randomized Control Trial
NCT05196867 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Detect and Expunge Concealed Tumors of the Liver
NCT06141564 ·Status: ACTIVE_NOT_RECRUITING
-
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
NCT02060565 ·Status: RECRUITING
-
Prognostic Models for HCC Based on Tumor Micronecrosis
NCT05837065 ·Status: UNKNOWN
-
MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali Patients
NCT03227510 ·Status: UNKNOWN
-
Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma
NCT02730611 ·Status: COMPLETED
-
Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study)
NCT03852238 ·Status: COMPLETED
-
Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)
NCT03156582 ·Status: COMPLETED
-
Prospective Cohort of Patients With Hepatocellular Carcinoma in France
NCT04348838 ·Status: RECRUITING